This announcement is a separate document:
联环药业关于终止实施2019年限制性股票激励计划暨调整回购价格并回购注销已授予但尚未解除限售的限制性股票的公告
Lianhuan Pharmaceutical\'s announcement on terminating the implementation of the 2019 Restricted Stock Incentive Plan, adjusting the repurchase price, and repurchasing and cancelling restricted stocks that have been granted but not yet lifted the sale rest
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.